News

/News

Real World Evidence in Action: The LRG Research Model

Although targeted medicine has brought about immense progress in cancer treatment, there are still enormous challenges regarding patient survival. Randomized clinical trials (RCTs) driven by lab-based research have been the gold standard for identifying [...]

By | 2018-08-15T13:07:09+00:00 August 15th, 2018|News, Research|

The Werners – Finding the New Normal Living with Wildtype GIST

Left to right: Arianna, Tiffany, Cameron, Bryce and Chris Werner Bryce Werner was a regular middle-schooler living an average 12-year-old life in Pennsylvania when suddenly everything was thrown wildly left of normal [...]

By | 2018-07-06T12:25:25+00:00 June 29th, 2018|Member Stories, News, Newsletter|

New Technology Developed Which Can Predict GIST Patient’s Response to Drugs with Amazing Accuracy

Researchers have developed a test that can accurately identify over 20% of GIST patients that are unlikely to respond to currently approved treatments. In addition, it can identify which patients need a higher dose [...]

By | 2018-07-09T09:57:06+00:00 June 29th, 2018|GIST Education, Mutational Testing, News, Newsletter|

GIST Updates from the ASCO Annual Meeting 2018

Executive Director, Norman Scherzer, and Real World Evidence Data Scientist, Dr. Yu Wang, of the Life Raft Group recently attended the ASCO (American Society of Clinical Oncologists) 2018 meeting in Chicago. Dr. Wang describes [...]

By | 2018-07-05T20:42:52+00:00 June 18th, 2018|Clinical Trials, News, Research|

ISPOR Conference Sheds Light on Patient Experience Data

In May 2018, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), invited the Life Raft Group to the ISPOR 10th Patient Representatives Roundtable during the ISPOR 2018 conference in Baltimore, MD. Dr. Yu [...]

By | 2018-06-22T11:15:03+00:00 June 15th, 2018|News, Patient Data|

Deciphera Pharmaceuticals Announces the Start of Phase 3 Clinical Trial with DCC-2618 in GIST

On January 4th, 2018 Deciphera Pharmaceuticals, Inc, announced the start of the Phase 3 INVICTUS trial. This randomized trial is for 4th line GIST patients that have failed (or are intolerant) the [...]

By | 2018-06-13T09:30:09+00:00 January 9th, 2018|Clinical Trials, News|

It’s a Journey: Our Experience on Clinical Trials

By Jennifer Moore, LRG MemberI was waiting in line to pick up a new prescription for Gleevec when my husband ran in and told me to forget it. After two surgeries, a year on 400 [...]

By | 2018-07-30T10:26:09+00:00 December 28th, 2017|Clinical Trials, Member Stories, News, Newsletter|

Recent Posts

Upcoming Events

  1. Michigan GDOL 2018

    Michigan GDOL 2018

    October 27 @ 8:00 AM - 3:00 PM
  2. NTFC

    Night to Fight Cancer

    November 7 @ 6:00 PM - 11:00 PM